Alveolus Bio retweeted
Had a great time talking to @Amyshahmd on her podcast Save Yourself with Dr.Amy Shah! We had an engaging conversation covering health and wellness & the science behind @resbiotic & @AlveolusBio.
Also discussed the importance of academic commercialization and translation of lab science into ‘products and drugs’ to make actual impact.
Full podcast here: youtu.be/ZdtT_uIvKlo?si=h1Jl…
Alveolus Bio retweeted
Thrilled to share our team’s @NatureComms paper on the 1st inhaled live biotherapeutics for chronic lung disease! Years of hard work & bold thinking led us to engineer “air as medicine.” Proud to see this work moving forward at @AlveolusBio with phase 1b trials soon! @UABHeersink @UABNews @anupamuab @uabpeds @atscommunity @ATS_RCMB @UABInnovation
nature.com/articles/s41467-0…
Alveolus Bio retweeted
Was great attending @PASMeeting with our @uabpeds colleagues, catching up with academic friends and exploring Toronto with @ResBiotic team!
Thanks to all who attended our talks on tantalizing therapeutics for BPD this morning!
Alveolus Bio retweeted
Thanks @dougnoll, @AuthorityMgzine and medium.com for this interview! link.medium.com/sRKvS8ZD4Ib
@ResBiotic @AlveolusBio
@UABNews @uabmedicine @UABHeersink @UABInnovation
Alveolus Bio retweeted
Pleased to be presenting @AlveolusBio’s resMIT technology at @atscommunity #RIS2023.
Ping me if you are in DC and want to learn more about our @nih_nhlbi @NHLBI_SBIR funded technologies. @UABHeersink @uabpeds @UABMHIBI @UABPulmonary @UABInnovation @UABMicrobiome
Alveolus Bio retweeted
A recent study led by @AlveolusBio Founder, Vivek Lai M.D. found that experimental microbial dysbiosis in a preclinical model induces a redox imbalance & lung damage in neonatal mice which can be ameliorated using a live biotherapeutic mixture of bacteria. bit.ly/3P8BV8t
Alveolus Bio retweeted
A live biotherapeutic product reduces lung damage in mouse model of chronic lung disease uab.edu/news/research/item/1… @UABMHIBI @UABPulmonary @uabpeds @UABLungHealth @UABMicrobiome @UABNews @UABInnovation #microbiome @KentWillisMD @AlveolusBio
Our Founder & CEO @CVivekLaL discussing New Frontiers in Microbiome Therapeutics: Inhaled LBPs for Chronic Lung Disease, at Boston today. @MTIG_News @microbiome_news @MicrobiomePost @KR_Microbiome @UABNews #microbiome #lbp #lunghealth #respiratory @PRI_Microbiome
We will be presenting a corporate overview at Biotech Showcase next Tuesday! With #JPM22 and @EBDgroup’s #BiotechShowcase going virtual this year, registrants can tune in live or find a recording in the event center after the show.
Details👉 alveolusbio.com/2022/01/alve…